Enfermedades Desmielinizantes.pósters

Browse by

Recent Submissions

A Comprehensive Assessment of Progression Independent of Relapse Activity in a Cohort of Patients with Secondary Progressive Multiple Sclerosis (P8-6.010)

Zarate, María Agustina; Marrodán, Mariano; Piedrabuena, María Agustina; Fiol, Marcela Paula; Ysrraelit, María Célica; Correale, Jorge (American Academy of Neurology, 2024-04-09)

Objective: To analyze characteristics of patients with secondary progressive Multiple Sclerosis (SPMS) exhibiting Progression Independent of Relapse Activity (PIRA) and to identify factors contributing to earlier ...
Long-term Effect of Ofatumumab on Serum Immunoglobulin Levels in Patients with Relapsing Multiple Sclerosis (P9-6.007)

Bar-Or, Amit; Wiendl, Heinz; de Seze, Jerome; Correale, Jorge; Cross, Anne H.; Derfuss, Tobías; Selmaj, Krzysztof; Winthrop, Kevin; Giacomini, Paul Steven; Sacca, Francesco; Hu, Xixi; Sullivan, Roseanne; Jehl, Valentine; Boer, Ibolya; Bhatt, Alit; Hauser, Stephen L. (American Academy of Neurology, 2024-03-09)
Iron metabolism in oligodendrocytes and astrocytes: friend or foe?

Pasquini, Juana María; Rosato-Siri, María Victoria; Martino Adami, Pamela V.; Guitart, María Eugenia; Marcora, María Silvina; Morelli, Laura; Correale, Jorge (Reunión de Sociedades de Biociencias, 2021-11)

Recent reports show that astrocytes (AST) are able to create a permissive environment for remyelination through their action on oligodendrocyte (OLG) precursor migration, proliferation, and differentiation. When ...
Effect of Ofatumumab on Serum Immunoglobulin Levels and Infection Risk in Patients With Relapsing Multiple Sclerosis Over 3.5 Years

Wiendl, Heinz; de Seze, Jerome; Bar-Or, Amit; Correale, Jorge; Cross, Anne H.; Kappos, Ludwig; Selmaj, Krzysztof; Winthrop, Kevin; Giacomini, Paul Steven; Sacca, Francesco; Das Gupta, Ayan; Jehl, Valentine; Pingili, Ratnakar; Mancione, Linda; Zielman, Ronald; Hauser, Stephen L. (37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, 2021-10)

Resumen no disponible
LB82 Effect of Ofatumumab on Serum Immunoglobulin Levels and Infection Risk in Relapsing Multiple Sclerosis Patients from the Phase 3 ASCLEPIOS I and II Trials

de Seze, Jerome; Bar-Or, Amit; Correale, Jorge; Cross, Anne H.; Kappos, Ludwig; Selmaj, Krzysztof; Wiendl, Heinz; Kerloeguen, Cecile; Goodyear, Alexandra; Pingili, Ratnakar; Sullivan, Roseanne; Gupta, Ayan Das; Jehl, Valentine; Häring, Dieter A.; Merschhemke, Martin; Hauser, Stephen L. (Wiley, 2020-05)
LB62 Ofatumumab vs Teriflunomide in Relapsing Multiple Sclerosis: Analysis of No Evidence of Disease Activity (NEDA-3) from ASCLEPIOS I and II Trials

Hauser, Stephen L.; Bar-Or, Amit; Cohen, Jeffrey A.; Comi, Giancarlo; Correale, Jorge; Coyle, Patricia K.; Cross, Anne H.; de Seze, Jerome; Montalban, Xavier; Selmaj, Krzysztof; Wiendl, Heinz; Willi, Roman; Li, Bingbing; Häring, Dieter A.; Ramnathan, Krishnan; Merschhemke, Martin; Kappos, Ludwig (Wiley, 2020-05-27)
Volumetric Analysis and Densitiy of Extraocular Muscles in patients with Myasthenia Gravis (P5.4-036)

Kohler, Alejandro Alfredo; Farez, Mauricio Franco; Rivero, Alberto Daniel (AAN, 2019-05-09)

Objective: To analyze the volumetric and density characteristics of the extraocular muscles (EOM) in patients with Myasthenia Gravis (MG). Background: MG is an autoimmune disease that mainly involves EOM. Myopathies ...
Corticosteroids affect the dynamics of multiple sclerosis lesions formation (P3.2-079)

Gaitán, María Inés; De Pino, Gabriela; Ysrraelit, María Célica; Michelin, Gabriela; Yáñez, Paulina; Correale, Jorge (AAN, 2019-05-07)

Objective: To obtain in-vivo evidence of early dynamics of multiple sclerosis (MS) lesions formation and changes that corticosteroids may induce. Background: MRI showed that the development of MS lesions is dynamic and ...
Human MAIT Cell Response Shows Subset Diversity in Multiple Sclerosis (P2.2-089)

Correale, Jorge; Carnero Contentti, Edgar; Farez, Mauricio Franco (AAN, 2019-04-16)

Objective: To investigate cytotoxic activity heterogeneity in MAIT cell populations from MS patients Background: MAIT cells are a subset of innate T lymphocytes characterized by expression of an invariant TCR α-chain ...
Vasculitic Peripheral Neuropathy, differences between Systemic and Non-Systemic etiologies. (P2.4-008)

Castiglione, Juan Ignacio; Marrodán, Mariano; Taratuto, Ana Lía; Alessandro, Lucas; Brand, Patricio; Barroso, Fabio Adrián (AAN, 2019-04-16)

Objective: The objective of this study is to differentiate the clinical presentation, complementary studies and evolution between the Systemic Vasculitis (SV) vs Non-Systemic Vasculitic Neuropathy (NSVN) attended in our ...
Differential Diagnosis in Late Onset Multiple Sclerosis

Yorio, Florencia; Marrodán, Mariano; Farez, Mauricio Franco; Correale, Jorge (AAN, 2019-04-09)

Objective: To identify clinical-radiological characteristics of patients consulting with suspected Late Onset Multiple Sclerosis (LOMS). Background: LOMS is defined by clinical presentation after 50 years of age, being ...
The Natural History of Primary Progressive Multiple Sclerosis in Buenos Aires, Argentina (P4.2-070)

Bensi, Catalina; Marrodán, Mariano; Correale, Jorge; Farez, Mauricio Franco (Lippincott Williams & Wilkins, 2019-04-16)

Objective: To assess if clinical relapses and radiological disease activity correlates with neurological disability in primary progressive multiple sclerosis (PPMS), and to determine if there is any correlation between ...
Baseline Characteristics of Patients with Relapsing Multiple Sclerosis in ASCLEPIOS Phase 3 Trials of Ofatumumab Versus Teriflunomide (P3.2-096)

Kappos, Ludwig; Bar-Or, Amit; Cohen, Jeffrey A.; Comi, Giancarlo; Correale, Jorge; Coyle, Patricia K.; Cross, Anne H.; de Seze, Jerome; Montalban, Xavier; Selmaj, Krzysztof; Wiendl, Heinz; Leppert, David; Kerloeguen, Cecile; Willi, Roman; Häring, Dieter A.; Tomic, Davorka; Goodyear, Alexandra; Merschhemke, Martin; Hauser, Stephen L. (Lippincott Williams & Wilkins, 2019-04-16)

Objective: To present the baseline characteristics of patients enrolled in the ASCLEPIOS I and II trials. Background: ASCLEPIOS I and II are two Phase 3 trials of identical design that are being conducted simultaneously ...

Search DSpace

Browse

All of DSpace
This Collection
- By Issue Date
- Authors
- Titles
- Subjects

My Account

Discover

Statistics

RSS Feeds